prnewswire.comOptions Trading Now Available on Latest Five Tradr ETFs: CWVX, SMU, ASTX, GEVX and CEGX9 days ago
finance.yahoo.comAstex Pharmaceuticals Announce Key Data Presentations at the 36th EORTC-NCI-AACR Symposium10 months ago
finance.yahoo.comNovartis Kisqali shows deepening benefit in new analysis, reducing the risk of recurrence by 28.5% in a broad population of patients with early breast cancer11 months ago
businesswire.comOpenFold AI Research Consortium Welcomes Six New Members: Astex, Biogen, Congruence, Polaris Quantum, Psivant, and SandboxAQ12 months ago
businesswire.comElectra Therapeutics Builds Leadership Team with Appointment of Dr. Graham Parry as Chief Scientific Officer and Dr. Kim-Hien Dao as Chief Medical Officerabout 1 year ago
finance.yahoo.comNovartis highlights pioneering innovation in CML with data from Scemblix Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHAabout 1 year ago
finance.yahoo.comSmall Molecule Innovator API CDMO Research Report 2024: Global Market to Reach $47.14 Billion by 2030 driven by Increasing Demand for Small Molecule Drugs, and Surge in Clinical Trialsabout 1 year ago
finance.yahoo.comPheochromocytoma Pipeline Insight Report 2024, Featuring Genentech, Exelixis, Advanced Accelerator Applications, Enterome, FUJIFILM Toyama Chemical, Ipsen, Pfizer and Astex Pharmaceuticalsover 1 year ago
benzinga.comAstex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meetingover 1 year ago
CashuAstex Pharmaceuticals Inc.: Innovating Biotech with Fragment-Based Drug Design and Strategic Partnerships7 days ago
CashuAstex Pharmaceuticals Inc: Pioneering Innovative Drug Development in Oncology and Hematology9 days ago
CashuAstex Pharmaceuticals Inc. Leverages AI Innovations for Drug Discovery and Competitive Advantage20 days ago